Erika Vucko
Nurse Practitioner · Chicago, ILNPI 1467848366
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Biomarin Pharmaceutical Inc. accounts for 65.9% of it on its own, with 11 other manufacturers making up the rest. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $415.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$50K
- Amgen$17K
- PTC Therapeutics, Inc.$5K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Sanofi$1K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$867
- plus $907 from 6 others
Across 70 payments — averaging $4869.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$325K
- Ultragenyx Pharmaceutical Inc.$16K
What the payments were for
- Consulting fees$14,39019%
- Speaking & faculty fees$43,63957%
- Travel & lodging$11,44515%
- Food & beverage$6,9509%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 96 | $50,358 |
| Amgen(2 entities) | 45 | $16,553 |
| PTC Therapeutics, Inc. | 18 | $5,001 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $1,581 |
| Sanofi | 3 | $1,157 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $867 |
| Chiesi USA, Inc. | 4 | $644 |
| Cycle Pharmaceuticals Inc | 2 | $162 |
| Zevra Therapeutics Inc | 1 | $43 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $19 |
| Eton Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$76,424 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PalynziqPegvaliase-Pqpz | 12 | $224,061 |
| JavygtorSapropterin Dihydrochloride | 22 | $156,638 |
| Sapropterin Dihydrochloride | 26 | $113,092 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Biomarin Pharmaceutical Inc.Palynziq | $50,358 | $224,06112 claims |
| Cycle Pharmaceuticals IncJavygtor | $162 | $156,63822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Chicago
- Michelle MunroeChicago$64K
- Melanie SamardzijaChicago$42K
- Rana KennellyChicago$42K
- Fiona LynnChicago$41K
- Melissa DuckettChicago$30K
- Allison MorinChicago$27K
- Christy DavisChicago$19K
- Ariel HughChicago$17K
- Kelly DuganChicago$15K
- Annette PrihodaChicago$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.